S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 NOVOZYMES A/S/SSeattle GeneticsNeurocrine BiosciencesQiagenBIO-TECHNE
SymbolOTCMKTS:NVZMYNASDAQ:SGENNASDAQ:NBIXNYSE:QGENNASDAQ:TECH
Price Information
Current Price$43.90$83.86$93.75$27.54$202.03
52 Week RangeHoldBuyBuyHoldBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyHoldBuy
Consensus Price TargetN/A$87.92$106.56$34.86$206.80
% Upside from Price TargetN/A4.85% upside13.66% upside26.57% upside2.36% upside
Trade Information
Market Cap$13.13 billion$13.36 billion$8.54 billion$6.11 billion$7.61 billion
Beta0.751.951.220.851.21
Average Volume24,123900,711801,9301,234,371173,812
Sales & Book Value
Annual Revenue$2.28 billion$654.70 million$451.24 million$1.50 billion$714.01 million
Price / Sales5.7220.7119.034.1410.72
Cashflow$1.75 per shareN/A$0.52 per share$2.50 per share$6.00 per share
Price / Cash25.10N/A180.1811.0333.67
Book Value$6.10 per share$7.95 per share$5.30 per share$11.69 per share$30.78 per share
Price / Book7.2010.5517.692.366.56
Profitability
Net Income$511 million$-222,690,000.00$21.11 million$190.38 million$96.07 million
EPS$1.75($1.65)$0.22$1.34$3.80
Trailing P/E Ratio25.06N/A426.1420.5553.17
Forward P/E Ratio26.61N/A27.9018.0038.70
P/E Growth$2.05N/A$5.56$1.93$4.24
Net Margins22.31%-36.94%2.98%12.94%13.45%
Return on Equity (ROE)28.54%-17.16%0.46%12.10%13.20%
Return on Assets (ROA)16.00%-14.39%0.21%5.76%7.98%
Dividend
Annual Payout$0.50N/AN/AN/A$1.28
Dividend Yield1.14%N/AN/AN/A0.63%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio28.57%N/AN/AN/A33.68%
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%N/A0.96%0.54%0.42%
Current Ratio1.27%3.03%7.44%1.77%4.05%
Quick Ratio0.75%2.70%7.32%1.59%3.15%
Ownership Information
Institutional Ownership Percentage0.18%98.93%96.09%62.09%92.12%
Insider Ownership PercentageN/A33.80%4.30%9.00%4.20%
Miscellaneous
Employees6,4271,3025854,9522,250
Shares Outstanding297.00 million161.72 million91.58 million225.51 million37.89 million
Next Earnings Date10/23/2019 (Confirmed)10/29/2019 (Confirmed)11/4/2019 (Confirmed)10/30/2019 (Confirmed)10/29/2019 (Confirmed)
OptionableNot OptionableOptionableOptionableOptionableOptionable
 NOVOZYMES A/S/SSeattle GeneticsNeurocrine BiosciencesQiagenBIO-TECHNE

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel